Sign inGet started

Delagardelle Jeani

Insider CIK 1441563 · WHRT Director, 10% owner · CMRX 10% owner · MEIP 10% owner · CNCE 10% owner · IRTC 10% owner · RLYP · VSAR 10% owner · DRTX 10% owner · OXFD

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
IRTC iRhythm Technologies, Inc. C Conversion deriv2016-10-252016-10-25190,154— $00SEC↗
IRTC iRhythm Technologies, Inc. C Conversion deriv2016-10-252016-10-25610,136— $00SEC↗
IRTC iRhythm Technologies, Inc. C Conversion deriv2016-10-252016-10-25155,548— $00SEC↗
IRTC iRhythm Technologies, Inc. C Conversion deriv2016-10-252016-10-2572,389— $00SEC↗
IRTC iRhythm Technologies, Inc. P Buy2016-10-252016-10-2525,000$17.00 $425.0K1,741,589SEC↗
IRTC iRhythm Technologies, Inc. C Conversion2016-10-252016-10-251,716,589— $01,716,589SEC↗
MEIP MEI Pharma, Inc. S Sale2015-03-242015-03-261,601,390$1.97 $3.15M0SEC↗
VSAR Versartis, Inc. S Sale2014-12-182014-12-22150,000$19.01 $2.85M2,409,374SEC↗
MEIP MEI Pharma, Inc. S Sale2014-12-092014-12-1070,081$6.01 $421.2K1,601,390SEC↗
MEIP MEI Pharma, Inc. S Sale2014-12-082014-12-109,004$6.05 $54.5K1,671,471SEC↗
DRTX Durata Therapeutics, Inc. D To issuer2014-11-172014-11-183,028,439— $00SEC↗
VSAR Versartis, Inc. S Sale2014-11-112014-11-13800,000$19.37 $15.50M2,559,374SEC↗
VSAR Versartis, Inc. S Sale2014-09-292014-10-0112,556$20.02 $251.4K3,359,374SEC↗
VSAR Versartis, Inc. C Conversion deriv2014-03-272014-03-288,439,620— $00SEC↗
VSAR Versartis, Inc. C Conversion deriv2014-03-272014-03-281,349,433— $00SEC↗
VSAR Versartis, Inc. C Conversion deriv2014-03-272014-03-2820,942,466— $00SEC↗
VSAR Versartis, Inc. C Conversion deriv2014-03-272014-03-283,546,094— $00SEC↗
VSAR Versartis, Inc. C Conversion deriv2014-03-272014-03-283,050,019— $00SEC↗
VSAR Versartis, Inc. X Exercise deriv2014-03-272014-03-28759,565— $00SEC↗
VSAR Versartis, Inc. C Conversion deriv2014-03-272014-03-28759,565— $00SEC↗
VSAR Versartis, Inc. P Buy2014-03-272014-03-2860,000$21.02 $1.26M3,371,930SEC↗
VSAR Versartis, Inc. C Conversion2014-03-272014-03-281,821,084— $01,821,084SEC↗
VSAR Versartis, Inc. C Conversion2014-03-272014-03-2866,049— $03,311,930SEC↗
VSAR Versartis, Inc. C Conversion2014-03-272014-03-28308,356— $03,245,881SEC↗
VSAR Versartis, Inc. C Conversion2014-03-272014-03-28117,342— $02,937,525SEC↗
VSAR Versartis, Inc. C Conversion2014-03-272014-03-28265,219— $02,820,183SEC↗
VSAR Versartis, Inc. C Conversion2014-03-272014-03-28733,880— $02,554,964SEC↗
CMRX CHIMERIX INC J Other2014-03-182014-03-20700,000— $01,543,394SEC↗
CNCE CONCERT PHARMACEUTICALS, I C Conversion deriv2014-02-192014-02-21442,478— $00SEC↗
CNCE CONCERT PHARMACEUTICALS, I C Conversion deriv2014-02-192014-02-2177,522— $00SEC↗
CNCE CONCERT PHARMACEUTICALS, I C Conversion2014-02-192014-02-2113,721— $0107,327SEC↗
CNCE CONCERT PHARMACEUTICALS, I C Conversion2014-02-192014-02-2178,315— $093,606SEC↗
MEIP MEI Pharma, Inc. S Sale2013-11-212013-11-25365,000$8.25 $3.01M1,680,475SEC↗
RLYP Relypsa Inc C Conversion deriv2013-11-202013-11-20259,676— $00SEC↗
RLYP Relypsa Inc C Conversion deriv2013-11-202013-11-20497,093— $00SEC↗
RLYP Relypsa Inc J Other deriv2013-11-202013-11-2025,977— $025,977SEC↗
RLYP Relypsa Inc M Exercise deriv2013-11-202013-11-2025,977— $00SEC↗
RLYP Relypsa Inc C Conversion deriv2013-11-202013-11-20378,773— $00SEC↗
RLYP Relypsa Inc C Conversion deriv2013-11-202013-11-20541,960— $00SEC↗
RLYP Relypsa Inc C Conversion deriv2013-11-202013-11-20125,067— $00SEC↗
RLYP Relypsa Inc J Other deriv2013-11-202013-11-2017,671— $00SEC↗
RLYP Relypsa Inc C Conversion2013-11-202013-11-20497,093— $0497,093SEC↗
RLYP Relypsa Inc C Conversion2013-11-202013-11-20125,067— $01,924,626SEC↗
RLYP Relypsa Inc C Conversion2013-11-202013-11-20378,773— $01,257,599SEC↗
RLYP Relypsa Inc C Conversion2013-11-202013-11-20541,960— $01,799,559SEC↗
RLYP Relypsa Inc C Conversion2013-11-202013-11-20381,733— $0878,826SEC↗
RLYP Relypsa Inc M Exercise2013-11-202013-11-2025,977$9.18 $238.5K1,950,603SEC↗
RLYP Relypsa Inc F Tax w/h2013-11-202013-11-2021,691$11.00 $238.6K1,928,912SEC↗
RLYP Relypsa Inc P Buy2013-11-202013-11-20185,978$11.00 $2.05M2,114,890SEC↗
MEIP MEI Pharma, Inc. S Sale2013-05-082013-05-08100,000$8.45 $845.0K2,045,475SEC↗
MEIP MEI Pharma, Inc. S Sale2013-05-062013-05-08100,000$8.70 $870.0K2,145,475SEC↗
MEIP MEI Pharma, Inc. S Sale2013-04-192013-04-22157,300$8.43 $1.33M2,245,475SEC↗
MEIP MEI Pharma, Inc. S Sale2013-04-182013-04-22100,000$8.57 $857.0K2,402,775SEC↗
MEIP MEI Pharma, Inc. S Sale2013-02-192013-02-20300,000$6.80 $2.04M2,502,775SEC↗
MEIP MEI Pharma, Inc. S Sale2013-02-152013-02-20197,225$6.60 $1.30M2,802,775SEC↗
WHRT WORLD HEART CORP D To issuer deriv2012-08-022012-08-062,341,920$0.10 $234.2K0SEC↗
WHRT WORLD HEART CORP D To issuer2012-08-022012-08-066,063,603— $00SEC↗
DRTX Durata Therapeutics, Inc. C Conversion deriv2012-07-242012-07-2617,953,008— $00SEC↗
DRTX Durata Therapeutics, Inc. C Conversion2012-07-242012-07-262,244,126— $02,244,126SEC↗
DRTX Durata Therapeutics, Inc. P Buy2012-07-242012-07-26784,313$9.00 $7.06M3,028,439SEC↗